The World Health Organization (WHO) has issued a significant new guideline on the use of non-sugar sweeteners (NSS), commonly known as artificial or low-calorie sweeteners, recommending against their long-term use for controlling body weight or reducing the risk of noncommunicable diseases. This recommendation, based on a comprehensive review of available scientific evidence, suggests that while NSS might offer a temporary calorie reduction when substituting sugar, they do not provide a demonstrable benefit for sustained weight loss in either adults or children. The guideline also highlights potential associations between long-term NSS consumption and increased risks of certain chronic health conditions, prompting a re-evaluation of their role in a healthy diet.
The WHO’s decision stems from a systematic review of scientific literature, which encompassed a wide range of studies, including randomized controlled trials (RCTs) and observational cohort studies. The review aimed to provide evidence-based guidance on the efficacy and safety of NSS in relation to health outcomes. The findings indicated that replacing sugar-sweetened products with NSS did not lead to significant long-term reductions in body weight. While some clinical trials observed a reduction in calorie intake when NSS replaced sugar in foods and beverages, this effect was not consistently linked to sustained weight loss. Furthermore, the impact of NSS on satiety and hunger levels proved to be inconsistent, with some studies reporting reduced hunger and others suggesting an increased appetite with higher NSS consumption.
The observational data presented a more concerning picture regarding long-term health. Cohort studies indicated a potential association between the long-term consumption of NSS-containing beverages and an elevated risk of cardiovascular disease and premature death in adults. Additionally, higher intakes of NSS, whether in beverages or added to foods, were linked to an increased risk of developing type 2 diabetes. The WHO acknowledged the possibility of "reverse causation" in these observational findings. This phenomenon suggests that individuals who are already overweight, obese, or have metabolic risk factors might be more inclined to choose NSS as a perceived healthier alternative, thereby creating an association between NSS use and pre-existing health conditions rather than NSS causing these conditions. However, the review found no significant association between NSS consumption and an increased risk of cancer or cancer-related mortality.
Based on this comprehensive analysis, the WHO’s primary recommendation is for individuals to reduce their overall intake of sweet tastes, starting from early childhood. The organization emphasizes that NSS do not offer any nutritional value and therefore do not contribute positively to a healthy diet. The guideline lists common NSS, including acesulfame K, aspartame, saccharin, sucralose, and stevia. It is important to note that the WHO’s analysis did not include sugar alcohols, also known as polyols, such as maltitol, xylitol, and sorbitol, which are frequently used as sweeteners in various food and beverage products.
Expert Perspectives and Criticisms
While agreeing with the WHO’s overarching message to moderate sweet consumption, some experts from the Harvard T.H. Chan School of Public Health have raised specific criticisms regarding the meta-analysis underpinning the guideline. They pointed out that certain large-scale cohort studies, which included over 100,000 participants, were excluded from the WHO’s review. These omitted studies suggested that substituting sugar-sweetened beverages with artificially sweetened beverages was associated with less weight gain over time, a finding that aligns with results from smaller, short-term randomized controlled trials. Statistical modeling based on these excluded studies estimated that replacing one serving of a sugar-sweetened beverage with an artificially sweetened one could potentially lead to a 4% lower risk of total mortality, a 5% lower risk of cardiovascular disease-related mortality, and a 4% lower risk of cancer-related mortality.
Frank Hu, Chair of the Department of Nutrition at the Harvard T.H. Chan School of Public Health, offered a nuanced perspective on the role of NSS. He stated, "For habitual consumers of sugar-sweetened beverages, artificially sweetened beverages can be used as a temporary replacement, although the best choices would be water and unsweetened coffee or tea." This suggests that while NSS might serve as a transitional tool for individuals aiming to reduce sugar intake, they are not presented as an ideal long-term solution for optimal health. The emphasis remains on prioritizing water and unsweetened beverages as the healthiest choices.
Background on Non-Sugar Sweeteners
Non-sugar sweeteners have gained widespread popularity over the past several decades as consumers and food manufacturers sought alternatives to sugar to reduce calorie content and manage blood sugar levels. These sweeteners are significantly sweeter than sucrose (table sugar), meaning that only small amounts are needed to achieve the desired sweetness. Their development and introduction into the food supply have been a response to growing public health concerns about obesity, type 2 diabetes, and other diet-related chronic diseases.
The history of artificial sweeteners dates back to the late 19th and early 20th centuries with the discovery of saccharin and cyclamate. Aspartame, discovered in 1965, became widely adopted in the 1980s. More recently, high-intensity sweeteners like sucralose (derived from sugar but with a different chemical structure), acesulfame potassium, and steviol glycosides (derived from the stevia plant) have entered the market. These sweeteners are regulated by food safety authorities in different countries, which establish acceptable daily intake (ADI) levels based on extensive toxicological studies.
The debate surrounding the health effects of NSS has been ongoing, with scientific research yielding mixed results. While regulatory bodies generally consider approved NSS to be safe when consumed within established ADI limits, public perception and some scientific studies have raised questions about their long-term health impacts, particularly concerning metabolic health, gut microbiota, and potential links to chronic diseases. The WHO guideline represents a significant consolidation of evidence and a strong advisory statement based on the current understanding of NSS efficacy and safety.
The Aspartame Spotlight
Adding another layer to the discourse surrounding NSS, a recent risk assessment of aspartame by the International Agency for Research on Cancer (IARC), a specialized agency of the WHO, and the Joint Expert Committee on Food Additives (JECFA) has generated considerable attention. The IARC classified aspartame as a Group 2B carcinogen, meaning it has "limited evidence" of carcinogenicity in humans, specifically in relation to liver cancer. However, this classification does not equate to a definitive causal link. The IARC’s assessment is based on a review of available scientific literature, and its classifications indicate a possibility of carcinogenicity, not certainty.
Crucially, the JECFA reaffirmed its previously established acceptable daily intake (ADI) for aspartame, which remains at 40 mg per kilogram of body weight. This committee found that the evidence reviewed did not warrant a change to this guideline, affirming that consumption within this range is safe. For a 150-pound (approximately 68 kg) woman, this translates to a daily limit of about 2,727 mg of aspartame, equivalent to consuming approximately eleven 12-ounce cans of diet soda, as a single can typically contains around 250 mg of aspartame. The JECFA emphasized that the evidence on cancer risk in humans, based on both animal and human studies, was not convincing. They underscored the need for more extensive research, including longer-term follow-up studies and randomized controlled trials, to provide more definitive conclusions.
Broader Implications for Public Health and Food Industry
The WHO’s new guideline has significant implications for public health strategies, dietary recommendations, and the food and beverage industry. For consumers, it reinforces the importance of prioritizing whole, unprocessed foods and beverages and encourages a mindful approach to sweetness in the diet. The recommendation to reduce overall sweetness, particularly from an early age, aligns with broader public health goals of promoting healthier eating habits and preventing the development of diet-related chronic diseases.
For the food and beverage industry, the guideline may prompt a re-evaluation of product formulations and marketing strategies. While NSS have been instrumental in creating "low-sugar" and "diet" options, the WHO’s advisory suggests that these may not be the ultimate solution for long-term health. This could accelerate innovation towards products that rely on natural sweetness from fruits, offer less intense sweetness profiles, or focus on the inherent flavors of ingredients rather than added sweeteners. The industry will likely face increased scrutiny regarding the health claims associated with products containing NSS.
The guideline also highlights the ongoing need for robust scientific research. The discrepancies in findings between different types of studies (RCTs versus observational studies) and the exclusion of certain studies in the WHO’s meta-analysis underscore the complexity of nutritional science and the challenges in establishing definitive causal relationships. Future research should aim to address these limitations, focusing on well-designed, long-term studies that can provide clearer insights into the multifaceted effects of NSS on human health.
In conclusion, the WHO’s guidance on non-sugar sweeteners represents a pivotal moment in the ongoing discussion about their role in a healthy diet. By advising against their use for weight management and disease prevention and flagging potential long-term health risks, the organization is shifting the focus towards a more holistic approach to dietary sweetness. While NSS may continue to serve a purpose as a transitional tool for some, the ultimate goal, as articulated by public health experts, remains a reduction in overall sweet taste preference and a greater reliance on water and unsweetened beverages for optimal health.
